European stocks rise on signs of hope about omicron
KEY POINTS Investors reacted to a study out of South Africa suggesting a reduced risk of hospitalization and severe disease from omicron compared with delta . The U.S. Centers for Disease Control and Prevention authorized an antiviral Covid pill from Pfizer for people aged 12 and above at risk of severe illness . . . …
European stocks rise on signs of hope about omicron قراءة المزيد »